Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Jacobs

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Plos Neglected Tropical Diseases|January 28, 2020
In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontisAlexandra Ehrens, Christopher S Lunde, Robert T Jacobs, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Molecular Pharmacology|July 7, 2022
Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial LeadsMichelle M Butler, Samanthi L Waidyarachchi, Jinfeng Shao, et al.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Journal of Medicinal Chemistry|October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral LeishmaniasisCharles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.
Journal of Medicinal Chemistry|March 24, 2021
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazinesDaniel L Priebbenow, Mitch Mathiew, Da-Hua Shi, et al.
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Plos Neglected Tropical Diseases|January 28, 2020
In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontisAlexandra Ehrens, Christopher S Lunde, Robert T Jacobs, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Molecular Pharmacology|July 7, 2022
Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial LeadsMichelle M Butler, Samanthi L Waidyarachchi, Jinfeng Shao, et al.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Journal of Medicinal Chemistry|October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral LeishmaniasisCharles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.
Journal of Medicinal Chemistry|March 24, 2021
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazinesDaniel L Priebbenow, Mitch Mathiew, Da-Hua Shi, et al.
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 3